Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Deferred Taxes (2017 - 2026)

Corcept Therapeutics (CORT) has disclosed Deferred Taxes for 10 consecutive years, with -$13.1 million as the latest value for Q1 2026.

  • For Q1 2026, Deferred Taxes rose 4.34% year-over-year to -$13.1 million; the TTM value through Mar 2026 reached -$36.9 million, up 20.95%, while the annual FY2025 figure was -$37.5 million, 6.6% up from the prior year.
  • Deferred Taxes hit -$13.1 million in Q1 2026 for Corcept Therapeutics, up from -$15.2 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at $9.1 million in Q3 2025 and bottomed at -$17.8 million in Q2 2025.
  • Average Deferred Taxes over 5 years is -$9.1 million, with a median of -$9.9 million recorded in 2022.
  • Year-over-year, Deferred Taxes crashed 678.8% in 2022 and then surged 159.93% in 2025.
  • Corcept Therapeutics' Deferred Taxes stood at -$4.5 million in 2022, then grew by 17.8% to -$3.7 million in 2023, then decreased by 5.07% to -$3.9 million in 2024, then crashed by 293.52% to -$15.2 million in 2025, then grew by 13.65% to -$13.1 million in 2026.
  • According to Business Quant data, Deferred Taxes over the past three periods came in at -$13.1 million, -$15.2 million, and $9.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.